Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Martina Studnickova"'
Autor:
Veronika Fulova, Eliska Hostinska, Martina Studnickova, Karel Huml, Jana Zapletalova, Jan Halek, Radovan Pilka
Publikováno v:
Biomedical Papers, Vol 165, Iss 3, Pp 305-315 (2021)
Aims. The aim of this study was to evaluate the role of IL-6 point-of-care test in amniotic fluid obtained from serial amniocentesis in expectantly managed women with PPROM between 24 and 34 weeks of gestation. Methods. We conducted a prospective obs
Externí odkaz:
https://doaj.org/article/a429d6d60a7a4f37a8ce70b5a4c0ef67
Autor:
Jana Bohmova, Marek Lubusky, Iva Holuskova, Martina Studnickova, Romana Kratochvilova, Eva Krejcirikova, Veronika Durdova, Tereza Kratochvilova, Ladislav Dusek, Martin Prochazka, Radek Vodicka
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 564 (2020)
Noninvasive fetal RHD genotyping is an important tool for predicting RhD incompatibility between a pregnant woman and a fetus. This study aimed to assess a methodological approach other than the commonly used one for noninvasive fetal RHD genotyping
Externí odkaz:
https://doaj.org/article/606e908108164c52a748189d2dfdb6b9
Autor:
Jana, Böhmova, Radek, Vodicka, Marek, Lubusky, Iva, Holuskova, Martina, Studnickova, Romana, Kratochvilova, Eva, Krejcirikova, Maria, Janikova, Veronika, Durdová, Tereza, Dolezalová, Hana, Filipová, Ladislav, Dusek, Ishraq, Dhaifalah, Katherine, Vomackova, Marian, Kacerovsky, Martin, Prochazka, Radek, Vrtel
Publikováno v:
Fetal diagnosis and therapy. 40(1)
The clinical importance of assessing the fetal KEL genotype is to exclude 'K'-positive fetuses (genotype KEL1/KEL2) in 'K'-alloimmunized pregnant women (genotype KEL2/KEL2). Noninvasive assessment of the fetal KEL genotype is not yet available in the
Autor:
Marek, Lubusky, Ondrej, Simetka, Martina, Studnickova, Martin, Prochazka, Marta, Ordeltova, Katherine, Vomackova
Publikováno v:
Transfusion. 52(9)
The objective was to determine the incidence and volume of fetomaternal hemorrhage (FMH) in normal vaginal delivery and in delivery by cesarean section. Determination of these variables would enable optimalization of guidelines for D alloimmunization